vs
AMN HEALTHCARE SERVICES INC（AMN）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是AMN HEALTHCARE SERVICES INC的1.9倍（$1.4B vs $748.2M），瑞思迈净利率更高（27.6% vs -1.0%，领先28.6%），瑞思迈同比增速更快（11.0% vs 1.8%），过去两年瑞思迈的营收复合增速更高（7.9% vs -4.5%）
AMN医疗保健服务公司是美国领先的医疗人力资源解决方案提供商，主要为医院、诊所等各类医疗机构提供护士、医师、医技人员及其他临床、非临床岗位的临时与长期派遣服务，同时提供医护团队管理技术支持及相关咨询服务。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
AMN vs RMD — 直观对比
营收规模更大
RMD
是对方的1.9倍
$748.2M
营收增速更快
RMD
高出9.1%
1.8%
净利率更高
RMD
高出28.6%
-1.0%
两年增速更快
RMD
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $748.2M | $1.4B |
| 净利润 | $-7.7M | $392.6M |
| 毛利率 | 26.1% | 61.8% |
| 营业利润率 | 1.1% | 34.6% |
| 净利率 | -1.0% | 27.6% |
| 营收同比 | 1.8% | 11.0% |
| 净利润同比 | 95.9% | 13.9% |
| 每股收益（稀释后） | $-0.19 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMNRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $748.2M | $1.4B | ||
| Q3 25 | $634.5M | $1.3B | ||
| Q2 25 | $658.2M | $1.3B | ||
| Q1 25 | $689.5M | $1.3B | ||
| Q4 24 | $734.7M | $1.3B | ||
| Q3 24 | $687.5M | $1.2B | ||
| Q2 24 | $740.7M | $1.2B |
净利润AMNRMD
| Q2 26 | — | $392.6M | ||
| Q4 25 | $-7.7M | $392.6M | ||
| Q3 25 | $29.3M | $348.5M | ||
| Q2 25 | $-116.2M | $379.7M | ||
| Q1 25 | $-1.1M | $365.0M | ||
| Q4 24 | $-187.5M | $344.6M | ||
| Q3 24 | $7.0M | $311.4M | ||
| Q2 24 | $16.2M | $292.2M |
毛利率AMNRMD
| Q2 26 | — | 61.8% | ||
| Q4 25 | 26.1% | 61.8% | ||
| Q3 25 | 29.1% | 61.5% | ||
| Q2 25 | 29.8% | 60.8% | ||
| Q1 25 | 28.7% | 59.3% | ||
| Q4 24 | 29.8% | 58.6% | ||
| Q3 24 | 31.0% | 58.6% | ||
| Q2 24 | 31.0% | 58.5% |
营业利润率AMNRMD
| Q2 26 | — | 34.6% | ||
| Q4 25 | 1.1% | 34.6% | ||
| Q3 25 | 7.5% | 33.4% | ||
| Q2 25 | -18.8% | 33.7% | ||
| Q1 25 | 1.8% | 33.0% | ||
| Q4 24 | -27.6% | 32.5% | ||
| Q3 24 | 3.2% | 31.6% | ||
| Q2 24 | 5.1% | 31.2% |
净利率AMNRMD
| Q2 26 | — | 27.6% | ||
| Q4 25 | -1.0% | 27.6% | ||
| Q3 25 | 4.6% | 26.1% | ||
| Q2 25 | -17.7% | 28.2% | ||
| Q1 25 | -0.2% | 28.3% | ||
| Q4 24 | -25.5% | 26.9% | ||
| Q3 24 | 1.0% | 25.4% | ||
| Q2 24 | 2.2% | 23.9% |
每股收益（稀释后）AMNRMD
| Q2 26 | — | $2.68 | ||
| Q4 25 | $-0.19 | $2.68 | ||
| Q3 25 | $0.76 | $2.37 | ||
| Q2 25 | $-3.02 | $2.58 | ||
| Q1 25 | $-0.03 | $2.48 | ||
| Q4 24 | $-4.90 | $2.34 | ||
| Q3 24 | $0.18 | $2.11 | ||
| Q2 24 | $0.42 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.0M | $1.4B |
| 总债务越低越好 | $767.1M | $663.8M |
| 股东权益账面价值 | $642.1M | $6.3B |
| 总资产 | $2.1B | $8.5B |
| 负债/权益比越低杠杆越低 | 1.19× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资AMNRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $34.0M | $1.4B | ||
| Q3 25 | $52.6M | $1.4B | ||
| Q2 25 | $41.5M | $1.2B | ||
| Q1 25 | $55.8M | $932.7M | ||
| Q4 24 | $10.6M | $521.9M | ||
| Q3 24 | $30.6M | $426.4M | ||
| Q2 24 | $48.0M | $238.4M |
总债务AMNRMD
| Q2 26 | — | $663.8M | ||
| Q4 25 | $767.1M | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | $1.1B | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M |
股东权益AMNRMD
| Q2 26 | — | $6.3B | ||
| Q4 25 | $642.1M | $6.3B | ||
| Q3 25 | $644.4M | $6.1B | ||
| Q2 25 | $607.6M | $6.0B | ||
| Q1 25 | $715.1M | $5.5B | ||
| Q4 24 | $706.6M | $5.3B | ||
| Q3 24 | $890.7M | $5.2B | ||
| Q2 24 | $876.9M | $4.9B |
总资产AMNRMD
| Q2 26 | — | $8.5B | ||
| Q4 25 | $2.1B | $8.5B | ||
| Q3 25 | $2.1B | $8.3B | ||
| Q2 25 | $2.2B | $8.2B | ||
| Q1 25 | $2.4B | $7.6B | ||
| Q4 24 | $2.4B | $7.1B | ||
| Q3 24 | $2.7B | $7.2B | ||
| Q2 24 | $2.8B | $6.9B |
负债/权益比AMNRMD
| Q2 26 | — | 0.11× | ||
| Q4 25 | 1.19× | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | 1.49× | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.6M | — |
| 自由现金流经营现金流 - 资本支出 | $67.6M | — |
| 自由现金流率自由现金流/营收 | 9.0% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $233.8M | — |
8季度趋势，按日历期对齐
经营现金流AMNRMD
| Q2 26 | — | — | ||
| Q4 25 | $75.6M | $339.7M | ||
| Q3 25 | $22.7M | $457.3M | ||
| Q2 25 | $78.5M | $538.8M | ||
| Q1 25 | $92.7M | $578.7M | ||
| Q4 24 | $72.8M | $308.6M | ||
| Q3 24 | $66.7M | $325.5M | ||
| Q2 24 | $99.5M | $440.1M |
自由现金流AMNRMD
| Q2 26 | — | — | ||
| Q4 25 | $67.6M | $311.2M | ||
| Q3 25 | $14.8M | $414.4M | ||
| Q2 25 | $68.7M | $508.2M | ||
| Q1 25 | $82.7M | $557.9M | ||
| Q4 24 | $56.6M | $288.0M | ||
| Q3 24 | $47.4M | $307.7M | ||
| Q2 24 | $72.2M | $415.2M |
自由现金流率AMNRMD
| Q2 26 | — | — | ||
| Q4 25 | 9.0% | 21.9% | ||
| Q3 25 | 2.3% | 31.0% | ||
| Q2 25 | 10.4% | 37.7% | ||
| Q1 25 | 12.0% | 43.2% | ||
| Q4 24 | 7.7% | 22.5% | ||
| Q3 24 | 6.9% | 25.1% | ||
| Q2 24 | 9.8% | 33.9% |
资本支出强度AMNRMD
| Q2 26 | — | — | ||
| Q4 25 | 1.1% | 2.0% | ||
| Q3 25 | 1.2% | 3.2% | ||
| Q2 25 | 1.5% | 2.3% | ||
| Q1 25 | 1.4% | 1.6% | ||
| Q4 24 | 2.2% | 1.6% | ||
| Q3 24 | 2.8% | 1.5% | ||
| Q2 24 | 3.7% | 2.0% |
现金转化率AMNRMD
| Q2 26 | — | — | ||
| Q4 25 | — | 0.87× | ||
| Q3 25 | 0.77× | 1.31× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 9.54× | 1.05× | ||
| Q2 24 | 6.13× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
RMD
暂无分部数据
